Ocuphire Pharma Stock Annual Yield
| OCUPDelisted Stock | USD 1.13 0.06 5.04% |
Ocuphire Pharma fundamentals help investors to digest information that contributes to Ocuphire Pharma's financial success or failures. It also enables traders to predict the movement of Ocuphire Stock. The fundamental analysis module provides a way to measure Ocuphire Pharma's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Ocuphire Pharma stock.
Ocuphire |
Ocuphire Pharma Company Annual Yield Analysis
Ocuphire Pharma's Yield generally refers to the amount of cash that is paid back to the owner of a security over a specific time (usually one year). It is expressed as a percentage of current market price, and usually amounts to all the interests and/or dividends paid over a given period. A higher yield allows the shareholders to generate returns on their investments sooner. However, investors should also be aware that a high yield may be a result of market turmoil or increased price volatility.
Small firms, start-ups, or companies with high growth potential typically do not pay out dividends or distribute a lot of their profits. These companies will have small yield. Alternatively, more established companies, ETFs, and funds that invest in bonds will have higher yields.
CompetitionIn accordance with the recently published financial statements, Ocuphire Pharma has an Annual Yield of 0.0%. This indicator is about the same for the Biotechnology average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).
Did you try this?
Run Portfolio Center Now
Portfolio CenterAll portfolio management and optimization tools to improve performance of your portfolios |
| All Next | Launch Module |
Ocuphire Fundamentals
| Return On Equity | -0.36 | |||
| Return On Asset | -0.21 | |||
| Profit Margin | (0.86) % | |||
| Operating Margin | (7.49) % | |||
| Current Valuation | (6.57 M) | |||
| Shares Outstanding | 26.2 M | |||
| Shares Owned By Insiders | 7.33 % | |||
| Shares Owned By Institutions | 10.44 % | |||
| Number Of Shares Shorted | 930.64 K | |||
| Price To Book | 0.86 X | |||
| Price To Sales | 2.12 X | |||
| Revenue | 19.05 M | |||
| Gross Profit | (14.58 M) | |||
| EBITDA | (10.56 M) | |||
| Net Income | (9.99 M) | |||
| Cash And Equivalents | 17.15 M | |||
| Cash Per Share | 0.83 X | |||
| Total Debt | 4.04 M | |||
| Debt To Equity | 0.01 % | |||
| Current Ratio | 5.41 X | |||
| Book Value Per Share | 1.56 X | |||
| Cash Flow From Operations | (1.11 M) | |||
| Short Ratio | 10.10 X | |||
| Earnings Per Share | (0.54) X | |||
| Target Price | 16.75 | |||
| Number Of Employees | 14 | |||
| Beta | 0.31 | |||
| Market Capitalization | 34.84 M | |||
| Total Asset | 53.95 M | |||
| Retained Earnings | (81.47 M) | |||
| Working Capital | 49.91 M | |||
| Net Asset | 53.95 M |
About Ocuphire Pharma Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Ocuphire Pharma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Ocuphire Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Ocuphire Pharma based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Ocuphire Pharma
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Ocuphire Pharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ocuphire Pharma will appreciate offsetting losses from the drop in the long position's value.Moving against Ocuphire Stock
| 0.72 | CAT | Caterpillar Fiscal Year End 3rd of February 2025 | PairCorr |
| 0.7 | WMT | Walmart Aggressive Push | PairCorr |
| 0.68 | AXP | American Express Fiscal Year End 24th of January 2025 | PairCorr |
| 0.66 | IBM | International Business Fiscal Year End 22nd of January 2025 | PairCorr |
| 0.64 | AA | Alcoa Corp Fiscal Year End 15th of January 2025 | PairCorr |
The ability to find closely correlated positions to Ocuphire Pharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Ocuphire Pharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Ocuphire Pharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Ocuphire Pharma to buy it.
The correlation of Ocuphire Pharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Ocuphire Pharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Ocuphire Pharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Ocuphire Pharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Other Consideration for investing in Ocuphire Stock
If you are still planning to invest in Ocuphire Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Ocuphire Pharma's history and understand the potential risks before investing.
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |